Biologica Technologies will exhibit clinical data for its ProteiOS growth factor at the American Association of Neurological Surgeons Annual Scientific Meeting in New Orleans.
Here are three things to know.
1. ProteiOS is a novel allograft-derived growth factor which provides several osteoinductive, angiogenic and mitogenic growth factors in a lyophilized powder form.
2. It can be used with any scaffold FDA-approved for use with bone marrow aspirate.
3. ProteiOS growth factor is Biologica's first orthopedic and neurosurgery offering. The company launched ProteiOS in a targeted release in 2017 Q4; it is now available across the U.S.
More articles on biologics:
4 things to know about Datum Orthobiologics, a newly formed company